Key result
Theiler's murine encephalomyelitis virus L protein binds to the ankyrin repeats R1 and R2 of RNase L, preventing 2-5A from binding and thereby inhibiting RNase L dimerization and activation.
TMEV L protein represents a novel viral escape mechanism that directly binds RNase L ankyrin repeats to prevent 2-5A binding and subsequent RNase L activation.
Reveals RNase L evasion in a murine model; leaves open human relevance and therapeutic potential.
The OAS/RNase L pathway is one of the best-characterized effector pathways of the IFN antiviral response. It inhibits the replication of many viruses and ultimately promotes apoptosis of infected cells, contributing to the control of virus spread. However, viruses have evolved a range of escape strategies that act against different steps in the pathway. Here we unraveled a novel escape strategy involving Theiler's murine encephalomyelitis virus (TMEV) L* protein. Previously we found that L* was the first viral protein binding directly RNase L. Our current data show that L* binds the ankyrin repeats R1 and R2 of RNase L and inhibits 2'-5' oligoadenylates (2-5A) binding to RNase L. Thereby, L* prevents dimerization and oligomerization of RNase L in response to 2-5A. Using chimeric mouse hepatitis virus (MHV) expressing TMEV L*, we showed that L* efficiently inhibits RNase L in vivo. Interestingly, those data show that L* can functionally substitute for the MHV-encoded phosphodiesterase ns2, which acts upstream of L* in the OAS/RNase L pathway, by degrading 2-5A.
No takes yet. Share an insight, caveat, or question.
Drappier et al. (2018) studied Theiler's murine encephalomyelitis virus (TMEV) infection. Theiler's virus L protein was evaluated. Theiler's murine encephalomyelitis virus L protein binds to the ankyrin repeats R1 and R2 of RNase L, preventing 2-5A from binding and thereby inhibiting RNase L dimerization and activation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: